Trial Profile
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Almotriptan; Eletriptan; Frovatriptan; Naratriptan; Rizatriptan; Sumatriptan; Zolmitriptan
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2011 New trial record